single molecule array
Roswell Biotechnologies Provides Details on Molecular Electronics Device in Proof-of-Concept Study
Researchers said the paper had "impressive" results but that the technology still needs to prove itself with low target concentrations and complex samples.
Quanterix Raises $73.7M in IPO
The firm sold more than 4.9 million shares of common stock at $15 per share, raising $73.7 million to expand its commercial operations and grow its technology.
Quanterix Plans IPO
The firm plans to use the proceeds to expands its commercial operations, expand its existing technology, and support the launch of its new platform.
Quanterix Completes $8.5M Private Placement
The funding was led by T. Rowe Price and will be used by Quanterix to develop new instruments, expand the firm's assay menu, and other things.
Quanterix Invests in ImmunArray, Gains Access to Brain Injury Biomarker Portfolio
ImmunArray will use Quanterix's Simoa single-molecule array technology for biomarker analysis, with the potential to enrich its diagnostic panels.